These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2016248)

  • 1. Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study.
    Ratey J; Sovner R; Parks A; Rogentine K
    J Clin Psychiatry; 1991 Apr; 52(4):159-62. PubMed ID: 2016248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons.
    Ratey JJ; Sovner R; Mikkelsen E; Chmielinski HE
    J Clin Psychiatry; 1989 Oct; 50(10):382-4. PubMed ID: 2793836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buspirone in the management of major depression: a placebo-controlled comparison.
    Fabre LF
    J Clin Psychiatry; 1990 Sep; 51 Suppl():55-61. PubMed ID: 2211570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of buspirone on challenging behaviour in mentally retarded patients: an open prospective multiple-case study.
    Verhoeven WM; Tuinier S
    J Intellect Disabil Res; 1996 Dec; 40 ( Pt 6)():502-8. PubMed ID: 9004110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.
    Sramek JJ; Tansman M; Suri A; Hornig-Rohan M; Amsterdam JD; Stahl SM; Weisler RH; Cutler NR
    J Clin Psychiatry; 1996 Jul; 57(7):287-91. PubMed ID: 8666569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buspirone's efficacy in organic-induced aggression.
    Stanislav SW; Fabre T; Crismon ML; Childs A
    J Clin Psychopharmacol; 1994 Apr; 14(2):126-30. PubMed ID: 8195453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone.
    Petracca A; Nisita C; McNair D; Melis G; Guerani G; Cassano GB
    J Clin Psychiatry; 1990 Sep; 51 Suppl():31-9. PubMed ID: 2211564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Buspirone: a new non-benzodiazepine anxiolytic drug].
    Honorato J; Catalán M
    Rev Clin Esp; 1990 Apr; 186(6):286-91. PubMed ID: 2203117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buspirone in the long-term treatment of generalized anxiety disorder.
    Feighner JP
    J Clin Psychiatry; 1987 Dec; 48 Suppl():3-6. PubMed ID: 3320034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of buspirone, diazepam, and placebo in patients with chronic anxiety states.
    Olajide D; Lader M
    J Clin Psychopharmacol; 1987 Jun; 7(3):148-52. PubMed ID: 2885344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azapirones: an alternative to benzodiazepines for anxiety.
    Cadieux RJ
    Am Fam Physician; 1996 May; 53(7):2349-53. PubMed ID: 8638511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST; Park JH; Kim M
    Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Buspirone: a clinical review of a new, non-benzodiazepine anxiolytic".
    Uhlenhuth EH
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):109-16. PubMed ID: 6130067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and usefulness of buspirone as an anxiolytic drug in elderly versus young patients.
    Robinson D; Napoliello MJ; Schenk J
    Clin Ther; 1988; 10(6):740-6. PubMed ID: 3219687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy.
    Udelman HD; Udelman DL
    J Clin Psychiatry; 1990 Sep; 51 Suppl():46-50. PubMed ID: 2211568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buspirone for autistic disorder in a woman with an intellectual disability.
    Brahm NC; Fast GA; Brown RC
    Ann Pharmacother; 2008 Jan; 42(1):131-7. PubMed ID: 18056831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Buspirone in the treatment of Generalized Anxiety Disorders].
    Rzewuska M; Sobucka K
    Psychiatr Pol; 1993; 27(5):545-61. PubMed ID: 8255947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1986 Aug; 47(8):409-12. PubMed ID: 2874128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buspirone in clinical practice.
    Rickels K
    J Clin Psychiatry; 1990 Sep; 51 Suppl():51-4. PubMed ID: 2211569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.